London · Delayed Price · Currency is GBP · Price in GBX Applied Nutrition Earnings Call Transcripts
Fiscal Year 2026
-
Revenue grew 57% year-over-year to GBP 74.5 million, with adjusted EBITDA up 56% and margin stable at 28.9%. FY 2026 guidance was raised to GBP 140 million, supported by strong product innovation, global expansion, and resilient market demand.
Fiscal Year 2025
-
FY 2025 saw 24% revenue growth, strong profitability, and global expansion, with momentum continuing into FY 2026. Investments in capacity and innovation support further growth, while risks around space and input costs are being actively managed.
-
Revenue grew 19% year-over-year, exceeding guidance, with strong U.K. and European growth and robust D2C expansion. New partnerships and product launches underpin confidence in meeting GBP 100 million full-year revenue guidance, with margins and cash flow in line with expectations.